Figure S8 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma

Figure S8 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma

<p>Vaccinated D-neopeptides activate tumor-infiltrating antitumor T cells. (A) Circos plots provide an overview of the frequencies of Vβ-Jβ pairing in the primary and recurrent tumors. (B) Surface TCR β chain expression of the D-neopeptide-specific CD4+ TCCs was analyzed using FACs.</p>...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autor principal:	Jian Wang (15048011) (author)
Altres autors:	Tobias Weiss (15048014) (author), Marian C. Neidert (15048017) (author), Nora C. Toussaint (15048020) (author), Reza Naghavian (15048023) (author), Carla Sellés Moreno (15048026) (author), Magdalena Foege (15048029) (author), Paula Tomas Ojer (15048032) (author), Gioele Medici (15048035) (author), Ivan Jelcic (15048038) (author), Daniel Schulz (15048041) (author), Elisabeth Rushing (15048044) (author), Susanne Dettwiler (15048047) (author), Barbara Schrörs (15048050) (author), Joo Heon Shin (15048053) (author), Ron McKay (15048056) (author), Catherine J. Wu (14944480) (author), Andreas Lutterotti (15048059) (author), Mireia Sospedra (15048062) (author), Holger Moch (15048065) (author), Erich F. Greiner (15048068) (author), Bernd Bodenmiller (15048071) (author), Luca Regli (15048074) (author), Michael Weller (15037908) (author), Patrick Roth (15048077) (author), Roland Martin (15048080) (author)
Publicat:	2025
Matèries:	Cancer Immuno-oncology Immunotherapy Cancer vaccines Combination immunotherapy
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Figure S1 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
per: Jian Wang (15048011)
Publicat: (2025)

Figure S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
per: Jian Wang (15048011)
Publicat: (2025)

Figure S3 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
per: Jian Wang (15048011)
Publicat: (2025)

Figure S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
per: Jian Wang (15048011)
Publicat: (2025)

Figure S5 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
per: Jian Wang (15048011)
Publicat: (2025)

Figure S6 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
per: Jian Wang (15048011)
Publicat: (2025)

Figure S7 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
per: Jian Wang (15048011)
Publicat: (2025)

Table S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
per: Jian Wang (15048011)
Publicat: (2025)

Table S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
per: Jian Wang (15048011)
Publicat: (2025)

Table S1 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8<sup>+</sup> T Cells
per: Snehanshu Chowdhury (14957031)
Publicat: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
per: Hansol Lee (15054787)
Publicat: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
per: Hansol Lee (15054787)
Publicat: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
per: Hansol Lee (15054787)
Publicat: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
per: Hansol Lee (15054787)
Publicat: (2025)

Table S8 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
per: Stéphane Fattori (15048281)
Publicat: (2025)

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
per: Arianna Draghi (15126339)
Publicat: (2025)

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
per: Arianna Draghi (15126339)
Publicat: (2025)

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
per: Arianna Draghi (15126339)
Publicat: (2025)

Table S2, S4, S5, S6 and S7 from Single-Cell Analysis Reveals a CD4<sup>+</sup> T-cell Cluster That Correlates with PD-1 Blockade Efficacy
per: Hiroshi Kagamu (14961732)
Publicat: (2025)

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
per: Stéphane Fattori (15048281)
Publicat: (2025)

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
per: Stéphane Fattori (15048281)
Publicat: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
per: Stéphane Fattori (15048281)
Publicat: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
per: Stéphane Fattori (15048281)
Publicat: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
per: Stéphane Fattori (15048281)
Publicat: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
per: Stéphane Fattori (15048281)
Publicat: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
per: Stéphane Fattori (15048281)
Publicat: (2025)

Table S7 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
per: Stéphane Fattori (15048281)
Publicat: (2025)

CD38CD39 Population DEGs DS1 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
per: Ankita Mitra (17141783)
Publicat: (2025)

Teee Gene Signature DS2 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
per: Ankita Mitra (17141783)
Publicat: (2025)

Teee vs Treg Clusters DEGs DS3 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
per: Ankita Mitra (17141783)
Publicat: (2025)

Supplementary Data S1 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
per: Maria Lozano-Rabella (15056515)
Publicat: (2025)

Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
per: Maria Lozano-Rabella (15056515)
Publicat: (2025)

Supplementary Data S3 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
per: Maria Lozano-Rabella (15056515)
Publicat: (2025)

Table S1 from HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden–induced T-cell Exhaustion
per: Andrew Nguyen (17142197)
Publicat: (2025)

UMAP visualizations of extracted CD8<sup> + </sup> T and CD4<sup> + </sup> T cell barcodes, employed for downstream subsequent single-cell trajectory and classification analyses.
per: Fatemeh Keikha (20917848)
Publicat: (2025)

Immune landscape and CD8<sup>+</sup> T cell transition states in PTs, ECMs and MBMs.
per: Jingxin Zeng (18773484)
Publicat: (2025)

Image 8_Synthetic DNA co-immunization with vaccine-aligned common consensus nucleoprotein and hemagglutinin protects mice against lethal influenza infection with a single immunization.tif
per: Ebony N. Gary (2019478)
Publicat: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
per: Isha Mondal (16721699)
Publicat: (2025)

Cross sections for dissociative recombination of ArH<sup>+</sup> and NeH<sup>+</sup> calculated using MQDT
per: Åsa Larson (22660418)
Publicat: (2025)

Figure S.8 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
per: Xufeng Lu (14960724)
Publicat: (2025)

Cannot write session to /tmp/vufind_sessions/sess_eudephq7rtchqrqfc1m1s6kd58